Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cadmium Oxide, Hydrate
2. Monteponite
1. 1306-19-0
2. Cadmium Fume
3. Mfcd00010921
4. Oxocadmium
5. Ncgc00091341-01
6. Dsstox_cid_4715
7. Aska-rid
8. Dsstox_rid_77509
9. Dsstox_gsid_24715
10. Kadmu Tlenek [polish]
11. Caswell No. 136aa
12. Kadmu Tlenek
13. Cadmium(ii) Oxide
14. Ccris 115
15. Cas-1306-19-0
16. Hsdb 1613
17. Nci-c02551
18. Einecs 215-146-2
19. Unii-0h3kws8kj3
20. Epa Pesticide Chemical Code 236200
21. Cadmium Oxide Fume
22. Cadmium Oxide Brown
23. Cadmium Oxide [cadmium And Cadmium Compounds]
24. Ec 215-146-2
25. Dtxsid0024715
26. Niosh/ev1930000
27. Cadmium Oxide, Puriss., 99.0%
28. Baa30619
29. Tox21_111117
30. Tox21_202492
31. Akos015904020
32. Ncgc00260041-01
33. Cadmium Oxide, 99.998% (metals Basis)
34. Ev19300000
35. Cadmium Oxide, >=99.99% Trace Metals Basis
36. Cadmium Oxide, Powder, 99.5% Trace Metals Basis
37. Q196661
| Molecular Weight | 128.41 g/mol |
|---|---|
| Molecular Formula | CdO |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 129.898280 g/mol |
| Monoisotopic Mass | 129.898280 g/mol |
| Topological Polar Surface Area | 17.1 Ų |
| Heavy Atom Count | 2 |
| Formal Charge | 0 |
| Complexity | 2 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
MEDICATION (VET): AS AN ASCARICIDE IN SWINE
Budavari, S. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 1996., p. 266
Cadmium is a metallic impurity in various minerals. The two main cadmium exposure sources in general population are food and tobacco smoking...Cadmium is a cumulative toxic substance whose half-time for elimination is about 20 to 40 years and it is mainly stored in the liver and kidneys. Inhalation of cadmium oxide fumes may cause inhalation fevers or chemical pneumonitis. Cadmium chronic poisoning causes mainly renal tubulopathy and could be the cause of osteomalacia and diffuse osteoporosis. Cadmium is classified as certain carcinogen agent for humans by International Agency for Research on Cancer (IARC). The most relevant biological index exposure is the urinary cadmium. According to literature, no chelating agent can be still used in human cadmium poisonings. In France, some diseases caused by occupational exposure to cadmium may be compensated.
Andujar Pet al; Rev Med Interne 31 (2): 107-115 (2010)
1 YR INHALATION OF CADMIUM OXIDE ... BY DOGS @ LEVELS OF 3-7 MG/CU M DAILY RESULTED IN ... BLOOD CADMIUM CONCN AVG 0.22 MG% & URINE ... WERE 0.36 MG/L. MOST ... CADMIUM ... RETAINED IN LUNGS, CONSIDERABLE AMT IN KIDNEY & LIVER ... LESSER AMT IN BONE & TEETH. LACK OF EFFECT ... ATTRIBUTED TO LOW RATE OF SOLUBILITY ...
Patty, F. (ed.). Industrial Hygiene and Toxicology: Volume II: Toxicology. 2nd ed. New York: Interscience Publishers, 1963., p. 1014
... ARC-PRODUCED CD FUME PARTICLE DEPOSITION IN LARGE NUMBER OF 5 ANIMAL SPECIES AT LD50 DOSES ... /WITH/ PARTICULATE DIAMETER ... FROM 0.3 TO 0.5 MU ... /SHOWED/ AVG FUME DEPOSITION IN LUNG ... ABOUT SAME FOR ALL SPECIES, 11%, WITH RANGE BETWEEN 4.3 & 21.7% ...
Clayton, G. D. and F. E. Clayton (eds.). Patty's Industrial Hygiene and Toxicology: Volume 2A, 2B, 2C: Toxicology. 3rd ed. New York: John Wiley Sons, 1981-1982., p. 1573
RATS WHICH DIED WITHIN 3 DAYS OF EXPOSURE TO AEROSOL OF CADMIUM OXIDE (60 M UG/L FOR 30 MIN) SHOWED LUNG LEVEL OF 26.9 UG.
HADLEY JG ET AL; TOXICOL LETT 4 (2): 107 (1979)
For more Absorption, Distribution and Excretion (Complete) data for CADMIUM OXIDE (7 total), please visit the HSDB record page.
IN RATS, INTRATRACHEALLY ADMIN CADMIUM OXIDE TAGGED WITH (109)CD, HALF-LIFE IN LUNG WAS 4 HR ...
PMID:7394784 HADLEY JG ET AL; TOXICOL APPL PHARMACOL 54 (1): 156 (1980)
Rats were intratracheally... /dosed with/ 36.5 or 27.5 ug of cadmium (Cd) as soluble cadmium chloride (CdCl2) and insoluble cadmium oxide (CdO) salts. The retention of metal in lungs, liver and kidney was assessed by atomic adsorption spectrophotometer. The animals were ip primed with sheep red blood cells (SRBC) and assessed for the number of antibody forming cells in lung associated lymph nodes (LALN) and spleen. Both the compounds had similar retention of metal in lungs but CdO induced more pulmonary inflammatory and degradative changes than CdCl2. The larger influx of polymorphonuclear cells (PMNs) following CdO exposure appears to be due to the absence of protection afforded by Cd induced metallothionein cytoplasmic protein while the Cd metallothionein complex formed in the case of CdCl2 is more protective. However both forms of Cd had similar local immunosuppressive potential but CdO had more prolonged suppressive effect
Dogra S et al; Indian J Exp Biol 40 (3): 262-267(2002)
Surfactant lipids of the alveolar space protect the lung from various environmental stimuli. We investigated the influence of ultrafine (UF) CdO particles inhalation on two key enzymes involved in lung sphingolipid metabolism, serine palmitoyltransferase (SPT), and sphingomyelinase (SMase). Rats inhaled either 0.63 mg UF-CdO/cu m for 6 hr (group 1), or 1.08 mg UF-CdO/cu m 12 hr/day for 10 days (group 2). Two corresponding control groups inhaled filtered clean air. Additional rats intratracheally instilled with lipopolysaccharide (LPS) were used as positive controls. Semiquantitative reverse-transcription polymerase chain reaction (RT-PCR) of lung tissue showed a significant increase in the level of SPT mRNA (LCB2 subunit) expression in group 2 compared to the corresponding controls (p <0.01). Group 1 and LPS were not statistically different from control. No alteration in the mRNA level of SMase was detected in any exposure group. The immunohistochemical analysis showed that SPT (LCB2 subunit) localization was stronger in the alveolar type II cells of group 2 lungs compared to the corresponding controls. These results were correlated with alterations in ...cellular and biochemical parameters and lung morphology. Since SPT is the key enzyme for de novo sphingolipid synthesis in lung surfactant and SMase is responsible for sphingomyelin catabolism, we can postulate that high-dose UF-CdO exposure for 10 days induces an increase in sphingolipid synthesis in the type II cells of rat lungs that would not be promptly followed by its degradation.
Alessandrini F et al; Inhal Toxicol 15 (4): 343-356 (2003)
ABOUT THIS PAGE
21
PharmaCompass offers a list of Cadmium Oxide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cadmium Oxide manufacturer or Cadmium Oxide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cadmium Oxide manufacturer or Cadmium Oxide supplier.
PharmaCompass also assists you with knowing the Cadmium Oxide API Price utilized in the formulation of products. Cadmium Oxide API Price is not always fixed or binding as the Cadmium Oxide Price is obtained through a variety of data sources. The Cadmium Oxide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cadmium Oxide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cadmium Oxide, including repackagers and relabelers. The FDA regulates Cadmium Oxide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cadmium Oxide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cadmium Oxide supplier is an individual or a company that provides Cadmium Oxide active pharmaceutical ingredient (API) or Cadmium Oxide finished formulations upon request. The Cadmium Oxide suppliers may include Cadmium Oxide API manufacturers, exporters, distributors and traders.
Cadmium Oxide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cadmium Oxide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cadmium Oxide GMP manufacturer or Cadmium Oxide GMP API supplier for your needs.
A Cadmium Oxide CoA (Certificate of Analysis) is a formal document that attests to Cadmium Oxide's compliance with Cadmium Oxide specifications and serves as a tool for batch-level quality control.
Cadmium Oxide CoA mostly includes findings from lab analyses of a specific batch. For each Cadmium Oxide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cadmium Oxide may be tested according to a variety of international standards, such as European Pharmacopoeia (Cadmium Oxide EP), Cadmium Oxide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cadmium Oxide USP).
